Michael Scolaro

Michael Scolaro

Sep 27, 2017

Group 6 Copy 116
2
Please wait...

About This Project

We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

Blast off!

Browse Other Projects on Experiment

Related Projects

Can we noninvasively measure blood sugar for diabetes?

Better management of type 1 diabetes is moving towards anartificial pancreas. However, we need a better way...

Will vitamin D improve the health of patients with heart failure?

We are trying to determine if supplemental vitamin D in heart failure patients will improve heart function and...

Does bias about medical diagnosis link to expectations of mental health problems for infants and their parents?

If doctors think infants will have lower skill (e.g., less able to look and to smile at parents), does that...

Backer Badge Funded